Becton, Dickinson and Company – LSE:0R19.L
Becton, Dickinson and Company stock price today
Becton, Dickinson and Company stock price monthly change
Becton, Dickinson and Company stock price quarterly change
Becton, Dickinson and Company stock price yearly change
Becton, Dickinson and Company key metrics
Market Cap | 65.42B |
Enterprise value | 81.16B |
P/E | 46.90 |
EV/Sales | 4.09 |
EV/EBITDA | 17.87 |
Price/Sales | 3.34 |
Price/Book | 2.56 |
PEG ratio | 3.19 |
EPS | 5.26 |
Revenue | 19.83B |
EBITDA | 4.79B |
Income | 1.51B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 7.13% |
Oper. margin | 12.29% |
Gross margin | 42.06% |
EBIT margin | 12.29% |
EBITDA margin | 24.16% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBecton, Dickinson and Company stock price history
Becton, Dickinson and Company stock forecast
Becton, Dickinson and Company financial statements
| Mar 2023 | 4.82B | 460M | 9.54% |
|---|---|---|---|
| Jun 2023 | 4.87B | 407M | 8.34% |
| Sep 2023 | 5.08B | 108M | 2.12% |
| Mar 2024 | 5.04B | 537M | 10.64% |
| Mar 2024 | 5.04B | 537M | 10.64% |
|---|---|---|---|
| Sep 2025 | 5.68B | 1.19B | 20.93% |
| Oct 2025 | 5.68B | 1.18B | 20.82% |
| Dec 2025 | 5.27B | 0 |
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 77.14% |
|---|
| 2019 | 1.46% |
|---|---|
| 2020 | 1.64% |
| 2021 | 1.49% |
| 2022 | 1.66% |
| 2023 | 1.5% |
| Mar 2023 | 54394000000 | 28.70B | 52.77% |
|---|---|---|---|
| Jun 2023 | 53017000000 | 27.08B | 51.08% |
| Sep 2023 | 52780000000 | 26.98B | 51.12% |
| Mar 2024 | 54157000000 | 28.50B | 52.64% |
| Mar 2023 | 184M | -233M | 1.36B |
|---|---|---|---|
| Jun 2023 | 1.08B | -329M | -1.79B |
| Sep 2023 | 1.32B | 137M | -997M |
| Mar 2024 | 515M | -1.05B | 1.70B |
Becton, Dickinson and Company alternative data
| Aug 2023 | 77,000 |
|---|---|
| Sep 2023 | 77,000 |
| Oct 2023 | 77,000 |
| Nov 2023 | 77,000 |
| Dec 2023 | 73,000 |
| Jan 2024 | 73,000 |
| Feb 2024 | 73,000 |
| Mar 2024 | 73,000 |
| Apr 2024 | 73,000 |
| May 2024 | 73,000 |
| Jun 2024 | 70,000 |
| Jul 2024 | 70,000 |
Becton, Dickinson and Company other data
| Insider | Compensation |
|---|---|
| Mr. Vincent A. Forlenza (1953) Executive Chairman | $3,260,000 |
Mr. Patrick K. Kaltenbach (1963) Executive Vice President & Pres of the Life Sciences Segment | $2,030,000 |
| Mr. Thomas E. Polen Jr. (1973) Pres, Chief Executive Officer & Director | $1,930,000 |
| Mr. Christopher R. Reidy (1957) Executive Vice President, Chief Financial Officer & Chief Admin. Officer | $1,740,000 |
Mr. Alberto Mas (1961) Executive Vice President & Pres of the Medical Segment | $1,320,000 |
Jerry Flasz Executive Vice President of Global Services & Chief Information Officer | |
| Dr. John A. DeFord Executive Vice President of R&D and Chief Technology Officer | |
| Mr. Charles R. Bodner Senior Vice President of Corporation Fin. | |
| Mr. Thomas J. Spoerel Vice President, Controller & Chief Accounting Officer | |
Ms. Monique N. Dolecki Senior Vice President of Investor Relations |
-
What's the price of Becton, Dickinson and Company stock today?
One share of Becton, Dickinson and Company stock can currently be purchased for approximately $250.62.
-
When is Becton, Dickinson and Company's next earnings date?
Unfortunately, Becton, Dickinson and Company's (0R19.L) next earnings date is currently unknown.
-
Does Becton, Dickinson and Company pay dividends?
Yes, Becton, Dickinson and Company pays dividends and its trailing 12-month yield is 1.7% with 77% payout ratio. The last Becton, Dickinson and Company stock dividend of $0.79 was paid on 30 Jun 2020.
-
How much money does Becton, Dickinson and Company make?
Becton, Dickinson and Company has a market capitalization of 65.42B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.66% to 19.37B US dollars.
-
What is Becton, Dickinson and Company's stock symbol?
Becton, Dickinson and Company is traded on the LSE under the ticker symbol "0R19.L".
-
What is Becton, Dickinson and Company's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Becton, Dickinson and Company?
Shares of Becton, Dickinson and Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Becton, Dickinson and Company's key executives?
Becton, Dickinson and Company's management team includes the following people:
- Mr. Vincent A. Forlenza Executive Chairman(age: 72, pay: $3,260,000)
- Mr. Patrick K. Kaltenbach Executive Vice President & Pres of the Life Sciences Segment(age: 62, pay: $2,030,000)
- Mr. Thomas E. Polen Jr. Pres, Chief Executive Officer & Director(age: 52, pay: $1,930,000)
- Mr. Christopher R. Reidy Executive Vice President, Chief Financial Officer & Chief Admin. Officer(age: 68, pay: $1,740,000)
- Mr. Alberto Mas Executive Vice President & Pres of the Medical Segment(age: 64, pay: $1,320,000)
- Jerry Flasz Executive Vice President of Global Services & Chief Information Officer
- Dr. John A. DeFord Executive Vice President of R&D and Chief Technology Officer
- Mr. Charles R. Bodner Senior Vice President of Corporation Fin.
- Mr. Thomas J. Spoerel Vice President, Controller & Chief Accounting Officer
- Ms. Monique N. Dolecki Senior Vice President of Investor Relations
-
How many employees does Becton, Dickinson and Company have?
As Jul 2024, Becton, Dickinson and Company employs 70,000 workers, which is 4% less then previous quarter.
-
When Becton, Dickinson and Company went public?
Becton, Dickinson and Company is publicly traded company for more then 10 years since IPO on 5 Nov 2014.
-
What is Becton, Dickinson and Company's official website?
The official website for Becton, Dickinson and Company is bd.com.
-
Where are Becton, Dickinson and Company's headquarters?
Becton, Dickinson and Company is headquartered at 1 Becton Drive, Franklin Lakes, NJ.
-
How can i contact Becton, Dickinson and Company?
Becton, Dickinson and Company's mailing address is 1 Becton Drive, Franklin Lakes, NJ and company can be reached via phone at +20 18476800.
Becton, Dickinson and Company company profile:
Becton, Dickinson and Company
bd.comLSE
70,000
Medical - Equipment & Services
Healthcare
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Franklin Lakes, NJ 07417-1880
:
ISIN: US0758871091
:
